AP2C_HUMAN - dbPTM
AP2C_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AP2C_HUMAN
UniProt AC Q92754
Protein Name Transcription factor AP-2 gamma
Gene Name TFAP2C
Organism Homo sapiens (Human).
Sequence Length 450
Subcellular Localization Nucleus .
Protein Description Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer..
Protein Sequence MLWKITDNVKYEEDCEDRHDGSSNGNPRVPHLSSAGQHLYSPAPPLSHTGVAEYQPPPYFPPPYQQLAYSQSADPYSHLGEAYAAAINPLHQPAPTGSQQQAWPGRQSQEGAGLPSHHGRPAGLLPHLSGLEAGAVSARRDAYRRSDLLLPHAHALDAAGLAENLGLHDMPHQMDEVQNVDDQHLLLHDQTVIRKGPISMTKNPLNLPCQKELVGAVMNPTEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLNASLLGGVLRRAKSKNGGRSLREKLDKIGLNLPAGRRKAAHVTLLTSLVEGEAVHLARDFAYVCEAEFPSKPVAEYLTRPHLGGRNEMAARKNMLLAAQQLCKEFTELLSQDRTPHGTSRLAPVLETNIQNCLSHFSLITHGFGSQAICAAVSALQNYIKEALIVIDKSYMNPGDQSPADSNKTLEKMEKHRK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
10SumoylationWKITDNVKYEEDCED
CEECCCCCCCCCCCC
53.88-
10SumoylationWKITDNVKYEEDCED
CEECCCCCCCCCCCC
53.88-
11PhosphorylationKITDNVKYEEDCEDR
EECCCCCCCCCCCCC
21.9222210691
22PhosphorylationCEDRHDGSSNGNPRV
CCCCCCCCCCCCCCC
27.0422210691
42UbiquitinationAGQHLYSPAPPLSHT
CCCCCCCCCCCCCCC
34.92-
70UbiquitinationPYQQLAYSQSADPYS
HHHHHCCCCCCCCCC
16.44-
72UbiquitinationQQLAYSQSADPYSHL
HHHCCCCCCCCCCHH
28.79-
112UbiquitinationGRQSQEGAGLPSHHG
CCCCCCCCCCCCCCC
18.65-
115UbiquitinationSQEGAGLPSHHGRPA
CCCCCCCCCCCCCCC
30.60-
202UbiquitinationKGPISMTKNPLNLPC
CCCCCCCCCCCCCCC
48.1829967540
211UbiquitinationPLNLPCQKELVGAVM
CCCCCCHHHHHCCCC
60.7821963094
232PhosphorylationCSVPGRLSLLSSTSK
ECCCCCHHHCCCCCC
26.3851163003
235PhosphorylationPGRLSLLSSTSKYKV
CCCHHHCCCCCCEEE
36.5425159151
236PhosphorylationGRLSLLSSTSKYKVT
CCHHHCCCCCCEEEE
36.3529255136
237PhosphorylationRLSLLSSTSKYKVTV
CHHHCCCCCCEEEEH
26.3429255136
238PhosphorylationLSLLSSTSKYKVTVA
HHHCCCCCCEEEEHH
35.6230576142
239UbiquitinationSLLSSTSKYKVTVAE
HHCCCCCCEEEEHHH
49.5321963094
241UbiquitinationLSSTSKYKVTVAEVQ
CCCCCCEEEEHHHHH
34.8622817900
252PhosphorylationAEVQRRLSPPECLNA
HHHHHHCCCHHHHCH
36.2822617229
260PhosphorylationPPECLNASLLGGVLR
CHHHHCHHHHHHHHH
24.0524732914
271PhosphorylationGVLRRAKSKNGGRSL
HHHHHHHHCCCCHHH
30.3010049255
281UbiquitinationGGRSLREKLDKIGLN
CCHHHHHHHHHHCCC
56.40-
284UbiquitinationSLREKLDKIGLNLPA
HHHHHHHHHCCCCCC
49.46-
434PhosphorylationYMNPGDQSPADSNKT
HCCCCCCCCCCHHHH
27.1330278072
438PhosphorylationGDQSPADSNKTLEKM
CCCCCCCHHHHHHHH
42.1924732914
440AcetylationQSPADSNKTLEKMEK
CCCCCHHHHHHHHHH
59.4426051181
441PhosphorylationSPADSNKTLEKMEKH
CCCCHHHHHHHHHHH
44.3826074081
444AcetylationDSNKTLEKMEKHRK-
CHHHHHHHHHHHCC-
56.3126051181
444UbiquitinationDSNKTLEKMEKHRK-
CHHHHHHHHHHHCC-
56.31-
447UbiquitinationKTLEKMEKHRK----
HHHHHHHHHCC----
45.25-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
252SPhosphorylationKinasePKA-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
10KSumoylation

12072434

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AP2C_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MYC_HUMANMYCgenetic
22371483
KDM5B_HUMANKDM5Bgenetic
22371483
MYC_HUMANMYCphysical
22371483
KDM5B_HUMANKDM5Bphysical
22371483
UBC9_HUMANUBE2Iphysical
12072434
ERBB4_HUMANERBB4physical
20943952

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AP2C_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY.
Sumoylation
ReferencePubMed
"Transcription factor AP-2 interacts with the SUMO-conjugating enzymeUBC9 and is sumolated in vivo.";
Eloranta J.J., Hurst H.C.;
J. Biol. Chem. 277:30798-30804(2002).
Cited for: INTERACTION WITH UBE2I, AND SUMOYLATION AT LYS-10.

TOP